Tag Drugs
Perception study may explain promising depression therapy
Ketamine has been shown to relieve depression-like symptoms in animal studies. With human volunteers, researchers Sounak Mohanta and Yuri Saalmann concluded that the drug blocks "negative predictions" that are prominent in depressed patients.
Waisman Biomanufacturing partners with GigaGen to manufacture new COVID-19 drug
The drug, called GIGA-2050, uses a new approach similar to treating COVID-19 patients with convalescent plasma.
UW–Madison and UW Health selected as sites to test new COVID-19 vaccine
They are among the first sites in the country to study whether an investigational vaccine developed by the pharmaceutical company AstraZeneca can prevent the disease.
Long delays prescribing new antibiotics hinder market for needed drugs
A survey of 132 hospitals found that the delays could reduce the likelihood that drug companies will develop new antibiotics essential for treating diseases.
A stent-free future for common cardiovascular ailments
An interdisciplinary team of investigators from UW–Madison and Ohio State believes once the new approach to maintaining open blood vessels is fully developed, it could benefit millions of patients.
Study of inflammation’s link to diseases wins NIH grant
Inflammation "is likely implicated in almost every disease,” says researcher David Beebe — including cancer, cardiovascular conditions and autoimmune diseases.
Forecasting antibiotic resistance with a ‘weather map’ of local data
To help physicians choose the best antibiotic first, researchers in the School of Pharmacy and the State Cartographer's Office are drawing inspiration from the weather.
Ebola vaccine inches toward human clinical trials
The need for an Ebola vaccine is acute. Periodic outbreaks of the disease in sub-Saharan Africa, including an epidemic between 2013 and 2016, caused major loss of life and serious economic disruption.
Undocumented immigration doesn’t worsen drug, alcohol problems in U.S., study indicates
An increase in the proportion of the population that is undocumented is associated with fewer drug arrests, drunken driving arrests and drug overdoses.
Old bones lead to new strategy for drug delivery
An engineering team has developed a new way to seed biomedical devices with agents that promote tissue growth and healing.
UW-Madison advisory board aids cancer treatment statewide
The Precision Medicine Molecular Tumor Board has a dual mission: consulting with oncologists statewide about targeted drugs to battle out-of-control cancers; and amassing data on what works and what does not.
‘KinderMining’: Tackling big data sets by keeping things simple
A Morgridge Institute for Research team has unleashed a fast, simple and predictive text-mining tool that may turbocharge big biomedical pursuits such as drug repurposing and stem cell treatments.
Chemistry method expedites path to useful molecules for medicine
The new method gives chemists prospecting for bioactive molecules a new tool in the search for novel drugs or chemicals for agriculture.
Botulinum toxin may travel further than expected in nerve cells
Two specific toxins — including the popular drug Botox — have multiple uses for treating many neuromuscular conditions, including frown lines, disabling muscle spasms and migraine headaches.
Research may point to new ways to deliver drugs into bacteria
The results were surprising due to the breadth of the different proteins found to be involved, says biochemist Douglas Weibel.
When brain metabolism dips, desire goes up in monkeys on ‘female Viagra’
As “the female Viagra” comes to market, researchers are learning more about how the drug affects the brain.
Drug protects fertility and may prolong life in chemo-treated mice
A University of Wisconsin–Madison physician and her research team have shown that a heart medication can prevent ovarian damage and improve survival in adolescent mice after chemotherapy. The treatment also increased the number of their healthy offspring.
Pharmacy garden exhibits the roots, shoots and leaves of medicine
The garden of traditional medicinal plants at the entrance of Rennebohm Hall on the University of Wisconsin–Madison campus shows the deep plant roots of pharmaceuticals, says former Dean Jeanette Roberts, a professor of pharmacy.
Stem cell-derived ‘organoids’ help predict neural toxicity
A new system developed by scientists at the Morgridge Institute for Research and the University of Wisconsin–Madison may provide a faster, cheaper and more biologically relevant way to screen drugs and chemicals that could harm the developing brain.
Faster, smaller, cheaper: Technique could speed biologic drugs
Antibodies are specific molecules that can lock onto a particular cellular structure to start, stop or otherwise temper a biological process. Because they are so specific, antibodies are at the forefront of drug discovery. So drug companies want a faster route to step one: identifying which of the millions of possible antibodies will work against molecules that cause disease.